Clinical Trial Update: Four Arms, Multicenter Study of Tailored Regimens With Peginterferon Plus Ribavirin for Genotype 2 Chronic Hepatitis C [Phase 4]

View source ↗

Summary

A Phase 4 multicenter trial evaluating tailored regimens of pegylated interferon plus ribavirin for genotype 2 chronic hepatitis C has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Peginterferon (Pegylated interferon)
• Ribavirin (ribavirin)

Snippet

Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital | Conditions: Chronic Hepatitis C | Phase 4 | Status: COMPLETED